dglp2 procurement of expendable medical stores , sumatriptan 50 mg tab , ondansetron 8 mg tab , atenolol 50 mg tab , glycerin ( glycerol ) in bott of 1 kg , ether solvent , cetirizine dihydrochloride 10 mg tab , diclofenac 25mg/ml ip , 3ml inj , chlorhexidine gluconate 2% in 70% isopropyl alcoho , l 500ml bott , azelastine hcl 140 mcg + fluticasone propionate 50 mcg bp , nasal spray , terbinafine 1% cream tube of 10 gm , levocetirizine 5mg tab , chlorhexidine gluconate solution equivalent to 4% w/v with isopropanol<10% , ethoxylated alkylphenol<10% fatty acid diethanolamide<10% , acetic acid glacial<10% , 500ml bott with dispenser , hematinic tab/cap containing ( a ) ferrous fumarate with 100 mg elemental iron ( b ) folic acid 500mcg -1500mcg , insulin disposable syringe 1ml , vacuum blood collection tubes with needles : heparin 3ml , immunoglobulin intravenous 5 gm inj , multivitamin drops with minimum constituents having vit a 14-1500 iu/ml , vit b1 0 . 3-0 . 6mg/ml , vit b2 0 . 3-0 . 8 mg/ml , b6 0 . 2-0 . 6/ml , vit c 20-30mg/ml , vit d-200-400iu/ml , zinc-1mg/ml bott of 15ml , chlorzoxazone 500mg+diclofenac sodium 50mg+paracetamol 325 mg tab , hydroquinone 2% tube of 50 gm , losartan 25 mg tab , diclofenac gel 1% tube of 30 gm , saxagliptin 5 mg tab , insulin premixed biphasic 40 iu per ml ( 30% human neutral plus 70% human isophane insulin ) , 10 ml inj , antacid gel each 5ml containing dried aluminium hyroxide gel ip 250mg , magnesium hydroxide nf 250mg and methyl polysiloxane 50mg bott of 170 ml , vitamin b complex with a minimum concentration of vit b1-5mg , vit b6-3mg & vit b12-5mcg therapeutic tab/cap